SET DE REACTIVOS PARAGLICOHEMOGLOBINA POINTESCIENTIFIC
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DICIPA, S.A. DE C.V.·Registered July 12, 2022ELDISPOSITIVOESTÁINDICADOPARALADETERMINACIÓNCUANTITATIVADEGLICOHEMOGLOBINA(HBA1)PRESENTEEN LA SANGRE CON EL MÉTODO DE RESINA DEINTERCAMBIO CATIÓNICO. EL ANÁLISIS SE USA EN LAMONITORIZACÓNDELAGLUCOSAALARGOPLAZO,ENLASPERSONAS CON DIABETES MELLITUS. AGENTE DEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVOENLABORATORIOS CLÍNICOS O DE GABINETE.
THE DEVICE IS INDICATED FOR THE QUANTITATIVE DETERMINATION OF GLYCOHEMOGLOBIN (HBA1) PRESENT IN THE BLOOD WITH THE CATION EXCHANGE RESIN METHOD. THE ANALYSIS IS USED IN LONG-TERM GLUCOSE MONITORING IN PEOPLE WITH DIABETES MELLITUS. DIAGNOSTIC AGENTFORUSEINVITRO. FOR EXCLUSIVE USE IN CLINICAL OR CABINET LABORATORIES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DEDIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LADETERMINACIÓN DEGLICOHEMOGLOBINA (HBA 1)
- Trade Name (English)
- GLYCOHEMOGLOBIN (HBA 1) TEST
- Analysis ID
- 599R2022 SSA
- Registration Date
- July 12, 2022
- Name (Spanish)
- DICIPA, S.A. DE C.V.
- Name (English)
- DICIPA, S.A. DE C.V.
Access comprehensive regulatory information for SET DE REACTIVOS PARAGLICOHEMOGLOBINA POINTESCIENTIFIC (POINTESCIENTIFIC PARAGLYCOHEMOGLOBIN REAGENT SET) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 599R2022 SSA and manufactured by DICIPA, S.A. DE C.V.. The device was registered on July 12, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.